Gene variants of coagulation related proteins that interact with SARS-CoV-2

• David Holcomb ,

  Contributed equally to this work with: David Holcomb, Aikaterini Alexaki, Nancy Hernandez

  Roles Formal analysis, Investigation, Software, Writing – original draft

  Affiliation Center for Biologics Evaluation and Research, Office of Tissues and Advanced Therapies, Division of Plasma Protein Therapeutics, Food and Drug Administration, Silver Spring, Maryland, United States of America

  https://orcid.org/0000-0002-4712-7952

  ⨯
• Aikaterini Alexaki ,

  Contributed equally to this work with: David Holcomb, Aikaterini Alexaki, Nancy Hernandez

  Roles Writing – original draft, Writing – review & editing

  Affiliation Center for Biologics Evaluation and Research, Office of Tissues and Advanced Therapies, Division of Plasma Protein Therapeutics, Food and Drug Administration, Silver Spring, Maryland, United States of America

  https://orcid.org/0000-0003-2511-8569

  ⨯
• Nancy Hernandez ,

  Contributed equally to this work with: David Holcomb, Aikaterini Alexaki, Nancy Hernandez

  Roles Investigation, Visualization

  Affiliation Center for Biologics Evaluation and Research, Office of Tissues and Advanced Therapies, Division of Plasma Protein Therapeutics, Food and Drug Administration, Silver Spring, Maryland, United States of America

  https://orcid.org/0000-0002-8307-4704

  ⨯
• Ryan Hunt,

  Roles Investigation, Writing – review & editing

  Affiliation Center for Biologics Evaluation and Research, Office of Tissues and Advanced Therapies, Division of Plasma Protein Therapeutics, Food and Drug Administration, Silver Spring, Maryland, United States of America

  ⨯
• Kyle Laurie,

  Roles Investigation

  Affiliation Center for Biologics Evaluation and Research, Office of Tissues and Advanced Therapies, Division of Plasma Protein Therapeutics, Food and Drug Administration, Silver Spring, Maryland, United States of America

  https://orcid.org/0000-0002-5596-6692

  ⨯
• Jacob Kames,

  Roles Conceptualization, Writing – review & editing

  Affiliation Center for Biologics Evaluation and Research, Office of Tissues and Advanced Therapies, Division of Plasma Protein Therapeutics, Food and Drug Administration, Silver Spring, Maryland, United States of America

  https://orcid.org/0000-0002-1614-6915

  ⨯
• Nobuko Hamasaki-Katagiri,

  Roles Conceptualization, Writing – review & editing

  Affiliation Center for Biologics Evaluation and Research, Office of Tissues and Advanced Therapies, Division of Plasma Protein Therapeutics, Food and Drug Administration, Silver Spring, Maryland, United States of America

  https://orcid.org/0000-0003-4954-9435

  ⨯
• Anton A. Komar,

  Roles Funding acquisition, Writing – review & editing

  Affiliation Center for Gene Regulation in Health and Disease, Department of Biological, Geological and Environmental Sciences, Cleveland State University, Cleveland, Ohio, United States of America

  ⨯
• Michael DiCuccio ,

  Roles Conceptualization, Writing – review & editing

  * E-mail: dicuccio@ncbi.nlm.nih.gov (MD); Chava.kimchi-sarfaty@fda.hhs.gov (CKS)

  Affiliation National Center of Biotechnology Information, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Chava Kimchi-Sarfaty

  Roles Conceptualization, Funding acquisition, Methodology, Project administration, Writing – review & editing

  * E-mail: dicuccio@ncbi.nlm.nih.gov (MD); Chava.kimchi-sarfaty@fda.hhs.gov (CKS)

  Affiliation Center for Biologics Evaluation and Research, Office of Tissues and Advanced Therapies, Division of Plasma Protein Therapeutics, Food and Drug Administration, Silver Spring, Maryland, United States of America

  ⨯